We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Bipolar Disorder with Cognitive Impairments Study

A 6-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)

This study is currently closed to enrollment.

Study Purpose

The purpose of this study is to examine the efficacy of lurasidone for improving cognition in patients with bipolar disorder types I and II who are not experiencing any symptoms of depression or mania, but are still experiencing cognitive impairments (e.g. difficulty with concentration, problem solving, memory etc.). Participants will go through cognitive testing throughout the study to determine efficacy of the medication.

Who Can Participate

Participants between 19 and 65 years of age with bipolar disorder type I or II, and are currently stable on a mood stabilizer but still experiencing problems with cognition may be eligible for this study. Additional criteria will be assessed by a study doctor to determine your eligibility.